How to Protect Your Healthcare Company’s Legacy While Still Maximizing Price (Section 1/3)
How to Protect Your Healthcare Company’s Legacy While Still Maximizing Price (Section 1/3) Key Takeaways Why “Legacy vs. Price” Is a False Tradeoff in 2026 Healthcare M&A Buyers don’t only purchase EBITDA—they underwrite risk, retention, and continuity. If your brand, clinicians, and patient experience are fragile, the price gets discounted. If they’re durable, multiples rise. […]
Read More
How to Healthcare Company De-Risk Reimbursement Changes Before You Go to Market
How to Healthcare Company De-Risk Reimbursement Changes Before You Go to Market Key Takeaways Why Reimbursement Risk Is the Silent Deal Breaker When healthcare founders prepare to go to market, they often focus on growth metrics, provider expansion, and patient acquisition. What many underestimate is how deeply reimbursement stability influences buyer confidence. Reimbursement is not […]
Read More
How to Sell a Healthcare Company Without Spooking Staff, Patients, or Referral Partners
How to Sell a Healthcare Company Without Spooking Staff, Patients, or Referral Partners Key Takeaways Why Selling a Healthcare Company Feels Riskier Than Other Businesses Selling a healthcare company is fundamentally different from selling a typical operating business. You are not just transferring assets or revenue streams—you are transitioning relationships, clinical trust, and continuity of […]
Read More